- Home
- MPU vs CASI Comparison
MPU vs CASI Comparison
Compare MPU & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- CASI
- Stock Information
- Founded
- MPU 1989
- CASI 1991
- Country
- MPU Singapore
- CASI China
- Employees
- MPU N/A
- CASI N/A
- Industry
- MPU Transportation Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- CASI Health Care
- Exchange
- MPU Nasdaq
- CASI Nasdaq
- Market Cap
- MPU 66.0M
- CASI 58.8M
- IPO Year
- MPU 1998
- CASI 1996
- Fundamental
- Price
- MPU $1.71
- CASI $2.91
- Analyst Decision
- MPU
- CASI Strong Buy
- Analyst Count
- MPU 0
- CASI 1
- Target Price
- MPU N/A
- CASI $6.00
- AVG Volume (30 Days)
- MPU 115.9K
- CASI 54.4K
- Earning Date
- MPU 11-12-2024
- CASI 11-15-2024
- Dividend Yield
- MPU N/A
- CASI N/A
- EPS Growth
- MPU N/A
- CASI N/A
- EPS
- MPU N/A
- CASI N/A
- Revenue
- MPU $26,001,000.00
- CASI $22,055,000.00
- Revenue This Year
- MPU N/A
- CASI N/A
- Revenue Next Year
- MPU N/A
- CASI $134.79
- P/E Ratio
- MPU N/A
- CASI N/A
- Revenue Growth
- MPU 1444400.00
- CASI N/A
- 52 Week Low
- MPU $0.77
- CASI $2.05
- 52 Week High
- MPU $4.48
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- MPU 50.01
- CASI 34.42
- Support Level
- MPU $1.66
- CASI $2.86
- Resistance Level
- MPU $1.79
- CASI $3.47
- Average True Range (ATR)
- MPU 0.13
- CASI 0.48
- MACD
- MPU -0.02
- CASI -0.00
- Stochastic Oscillator
- MPU 15.63
- CASI 28.21
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.